InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration...
57 insider purchases on record · latest filing 2026-10-15.
Insiders have also filed 1 sale transaction at INM.